A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis

Robert W. Schnepp; Priya Khurana; Edward F. Attiyeh; Pichai Raman; Sara E. Chodosh; Derek A. Oldridge; Maria E. Gagliardi; Karina L. Conkrite; Shahab Asgharzadeh; Robert C. Seeger; Blair B. Madison; Anil K. Rustgi; John M. Maris; Sharon J. Diskin

doi:10.1016/j.ccell.2015.09.012

A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis

Robert W. Schnepp, Priya Khurana, Edward F. Attiyeh, Pichai Raman, Sara E. Chodosh, Derek A. Oldridge, Maria E. Gagliardi, Karina L. Conkrite, Shahab Asgharzadeh, Robert C. Seeger, Blair B. Madison, Anil K. Rustgi, John M. Maris, Sharon J. Diskin

Gastroenterology

Research output: Contribution to journal › Article › peer-review

60 Scopus citations

Abstract

A more complete understanding of aberrant oncogenic signaling in neuroblastoma, a malignancy of the developing sympathetic nervous system, is paramount to improving patient outcomes. Recently, we identified LIN28B as an oncogenic driver in high-risk neuroblastoma. Here, we identify the oncogene RAN as a LIN28B target and show regional gain of chromosome 12q24 as an additional somatic alteration resulting in increased RAN expression. We show that LIN28B influences RAN expression by promoting RAN Binding Protein 2 expression and by directly binding RAN mRNA. Further, we demonstrate a convergence of LIN28B and RAN signaling on Aurora kinase A activity. Collectively, these findings demonstrate that LIN28B-RAN-AURKA signaling drives neuroblastoma oncogenesis, suggesting that this pathway may be amenable to therapeutic targeting.

Original language	English
Pages (from-to)	599-609
Number of pages	11
Journal	Cancer Cell
Volume	28
Issue number	5
DOIs	https://doi.org/10.1016/j.ccell.2015.09.012
State	Published - Nov 9 2015

Access to Document

10.1016/j.ccell.2015.09.012

Link to publication in Scopus

Fingerprint Dive into the research topics of 'A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis'. Together they form a unique fingerprint.

Cite this

Schnepp, R. W., Khurana, P., Attiyeh, E. F., Raman, P., Chodosh, S. E., Oldridge, D. A., Gagliardi, M. E., Conkrite, K. L., Asgharzadeh, S., Seeger, R. C., Madison, B. B., Rustgi, A. K., Maris, J. M., & Diskin, S. J. (2015). A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis. Cancer Cell, 28(5), 599-609. https://doi.org/10.1016/j.ccell.2015.09.012

Schnepp, Robert W. ; Khurana, Priya ; Attiyeh, Edward F. ; Raman, Pichai ; Chodosh, Sara E. ; Oldridge, Derek A. ; Gagliardi, Maria E. ; Conkrite, Karina L. ; Asgharzadeh, Shahab ; Seeger, Robert C. ; Madison, Blair B. ; Rustgi, Anil K. ; Maris, John M. ; Diskin, Sharon J. / A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis. In: Cancer Cell. 2015 ; Vol. 28, No. 5. pp. 599-609.

@article{6a855b662a3449d2bb46367b6b865ef1,

title = "A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis",

abstract = "A more complete understanding of aberrant oncogenic signaling in neuroblastoma, a malignancy of the developing sympathetic nervous system, is paramount to improving patient outcomes. Recently, we identified LIN28B as an oncogenic driver in high-risk neuroblastoma. Here, we identify the oncogene RAN as a LIN28B target and show regional gain of chromosome 12q24 as an additional somatic alteration resulting in increased RAN expression. We show that LIN28B influences RAN expression by promoting RAN Binding Protein 2 expression and by directly binding RAN mRNA. Further, we demonstrate a convergence of LIN28B and RAN signaling on Aurora kinase A activity. Collectively, these findings demonstrate that LIN28B-RAN-AURKA signaling drives neuroblastoma oncogenesis, suggesting that this pathway may be amenable to therapeutic targeting.",

author = "Schnepp, {Robert W.} and Priya Khurana and Attiyeh, {Edward F.} and Pichai Raman and Chodosh, {Sara E.} and Oldridge, {Derek A.} and Gagliardi, {Maria E.} and Conkrite, {Karina L.} and Shahab Asgharzadeh and Seeger, {Robert C.} and Madison, {Blair B.} and Rustgi, {Anil K.} and Maris, {John M.} and Diskin, {Sharon J.}",

year = "2015",

month = nov,

day = "9",

doi = "10.1016/j.ccell.2015.09.012",

language = "English",

volume = "28",

pages = "599--609",

journal = "Cancer Cell",

issn = "1535-6108",

number = "5",

}

A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis. / Schnepp, Robert W.; Khurana, Priya; Attiyeh, Edward F.; Raman, Pichai; Chodosh, Sara E.; Oldridge, Derek A.; Gagliardi, Maria E.; Conkrite, Karina L.; Asgharzadeh, Shahab; Seeger, Robert C.; Madison, Blair B.; Rustgi, Anil K.; Maris, John M.; Diskin, Sharon J.

In: Cancer Cell, Vol. 28, No. 5, 09.11.2015, p. 599-609.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - A LIN28B-RAN-AURKA Signaling Network Promotes Neuroblastoma Tumorigenesis

AU - Schnepp, Robert W.

AU - Khurana, Priya

AU - Attiyeh, Edward F.

AU - Raman, Pichai

AU - Chodosh, Sara E.

AU - Oldridge, Derek A.

AU - Gagliardi, Maria E.

AU - Conkrite, Karina L.

AU - Asgharzadeh, Shahab

AU - Seeger, Robert C.

AU - Madison, Blair B.

AU - Rustgi, Anil K.

AU - Maris, John M.

AU - Diskin, Sharon J.

PY - 2015/11/9

Y1 - 2015/11/9

N2 - A more complete understanding of aberrant oncogenic signaling in neuroblastoma, a malignancy of the developing sympathetic nervous system, is paramount to improving patient outcomes. Recently, we identified LIN28B as an oncogenic driver in high-risk neuroblastoma. Here, we identify the oncogene RAN as a LIN28B target and show regional gain of chromosome 12q24 as an additional somatic alteration resulting in increased RAN expression. We show that LIN28B influences RAN expression by promoting RAN Binding Protein 2 expression and by directly binding RAN mRNA. Further, we demonstrate a convergence of LIN28B and RAN signaling on Aurora kinase A activity. Collectively, these findings demonstrate that LIN28B-RAN-AURKA signaling drives neuroblastoma oncogenesis, suggesting that this pathway may be amenable to therapeutic targeting.

AB - A more complete understanding of aberrant oncogenic signaling in neuroblastoma, a malignancy of the developing sympathetic nervous system, is paramount to improving patient outcomes. Recently, we identified LIN28B as an oncogenic driver in high-risk neuroblastoma. Here, we identify the oncogene RAN as a LIN28B target and show regional gain of chromosome 12q24 as an additional somatic alteration resulting in increased RAN expression. We show that LIN28B influences RAN expression by promoting RAN Binding Protein 2 expression and by directly binding RAN mRNA. Further, we demonstrate a convergence of LIN28B and RAN signaling on Aurora kinase A activity. Collectively, these findings demonstrate that LIN28B-RAN-AURKA signaling drives neuroblastoma oncogenesis, suggesting that this pathway may be amenable to therapeutic targeting.

UR - http://www.scopus.com/inward/record.url?scp=84946548440&partnerID=8YFLogxK

U2 - 10.1016/j.ccell.2015.09.012

DO - 10.1016/j.ccell.2015.09.012

M3 - Article

C2 - 26481147

AN - SCOPUS:84946548440

VL - 28

SP - 599

EP - 609

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 5

ER -